Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Xin Zhang's publication output changed over time?
ScholarIQpublication output · 2010–2023
Output grew0% over the shown period — from 1 works in 2010 to 1 in 2023.
1
1
1
1
1
1
1
1
2
1
2010201220132014201520182019202020222023
What are the most-cited papers on Xin Zhang?
ScholarIQmost cited works
Chronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes
Xing Deng, Xin Zhang, Weiping Li, Ren-Xin Feng, Lu Li, Gui-Rong Yi, Xiaonan Zhang, Chuan Yin, Hongyu Yu, Junping Zhang, Bin Lü, Lijian Hui, Wei‐Fen Xie
S128124174. 2018296 CitationsOPEN ACCESS
Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma
Beifang Ning, Jin Ding, Chuan Yin, Wei Zhong, Kun Wu, Xin Zeng, Wen Yang, Yue-Xiang Chen, Junping Zhang, Xin Zhang, Hongyang Wang, Wei‐Fen Xie
Cancer Research. 2010242 CitationsOPEN ACCESS
Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies
Helle Linnebjerg, Eric Chen Quin Lam, Mary Seger, David E. Coutant, Laiyi Chua, Chew Lan Chong, Maria Manuela Frederico Ferreira, Danny Soon, Xin Zhang
Diabetes Care. 201595 Citations
Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis
Huan Yang, Ji Wang, Xin Zhang, Yan Zhang, Zi-li Qin, Hua Wang, Xiaoyan Luo
JAMA Dermatology. 201985 CitationsOPEN ACCESS
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region
Chuan Yin, Peiqin Wang, Wenping Xu, Yuan Yang, Qing Zhang, Beifang Ning, Ping-Ping Zhang, Weiping Zhou, Wei‐Fen Xie, Wansheng Chen, Xin Zhang
S156174673. 201381 CitationsOPEN ACCESS
Related on ScholarIQ
Army Medical University
Institution
Chronic Liver Injury Induces Conversion of Biliary Epithelial Cells into Hepatocytes
Paper
Hepatocyte Nuclear Factor 4α Suppresses the Development of Hepatocellular Carcinoma
Paper
Comparison of the Pharmacokinetics and Pharmacodynamics of LY2963016 Insulin Glargine and EU- and US-Approved Versions of Lantus Insulin Glargine in Healthy Subjects: Three Randomized Euglycemic Clamp Studies
Paper
Application of Topical Phosphodiesterase 4 Inhibitors in Mild to Moderate Atopic Dermatitis
Paper
Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region
Paper